Literature DB >> 3008580

Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.

A C Collier, R C Barnes, H H Handsfield.   

Abstract

The prevalence of antibody to LAV/HTLV-III among homosexual men attending a community clinic and a sexually transmitted disease clinic in Seattle, Washington in early 1985 was 42 per cent and 32 per cent, respectively. Seropositivity was apparently not related to age or number of sexual partners. The high prevalence of LAV/HTLV-III seropositivity in an area where overt AIDS (acquired immune deficiency syndrome) is still relatively uncommon suggests that public health measures to prevent acquisition and transmission of LAV/HTLV-III should be a high priority even in areas with low incidences of AIDS.

Entities:  

Mesh:

Year:  1986        PMID: 3008580      PMCID: PMC1646607          DOI: 10.2105/ajph.76.5.564

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Screening for gonorrhea and syphilis in the gay baths--Denver, Colorado.

Authors:  F N Judson; K G Miller; T R Schaffnit
Journal:  Am J Public Health       Date:  1977-08       Impact factor: 9.308

2.  Prevalence of antibodies to AIDS-associated retrovirus in single men in San Francisco.

Authors:  R E Anderson; J A Levy
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

Review 3.  Sexually transmitted diseases and homosexuality.

Authors:  D G Ostrow; N L Altman
Journal:  Sex Transm Dis       Date:  1983 Oct-Dec       Impact factor: 2.830

4.  National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results.

Authors:  H W Jaffe; K Choi; P A Thomas; H W Haverkos; D M Auerbach; M E Guinan; M F Rogers; T J Spira; W W Darrow; M A Kramer; S M Friedman; J M Monroe; A E Friedman-Kien; L J Laubenstein; M Marmor; B Safai; S K Dritz; S J Crispi; S L Fannin; J P Orkwis; A Kelter; W R Rushing; S B Thacker; J W Curran
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

5.  The gay report on sexually transmitted diseases.

Authors:  W W Darrow; D Barrett; K Jay; A Young
Journal:  Am J Public Health       Date:  1981-09       Impact factor: 9.308

6.  Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

Authors:  F Brun-Vezinet; C Rouzioux; F Barre-Sinoussi; D Klatzmann; A G Saimot; W Rozenbaum; D Christol; J C Gluckmann; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

7.  Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

Authors:  J J Goedert; M G Sarngadharan; R J Biggar; S H Weiss; D M Winn; R J Grossman; M H Greene; A J Bodner; D L Mann; D M Strong
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

8.  Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.

Authors:  M T Schreeder; S E Thompson; S C Hadler; K R Berquist; A Zaidi; J E Maynard; D Ostrow; F N Judson; E H Braff; T Nylund; J N Moore; P Gardner; I L Doto; G Reynolds
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

9.  AIDS and sexual behavior reported by gay men in San Francisco.

Authors:  L McKusick; W Horstman; T J Coates
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

10.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

View more
  2 in total

Review 1.  Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review.

Authors:  M van der Graaf; R J Diepersloot
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

2.  Risk behavior for HIV transmission among gay men surveyed in Seattle bars.

Authors:  S Steiner; A L Lemke; R A Roffman
Journal:  Public Health Rep       Date:  1994 Jul-Aug       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.